In contrast, IDH1 exhibited the highest mutation frequency in the low-aging CAF score group, which was consistent with the well-identified concept that IDH mutation was associated with better prognosis in gliomas (Turkalp et al., 2014). The gene discussed is IDH1; the disease is central nervous system cancer.